Is GLP-3 RT approved in Canada?

No. Health Canada has not authorized GLP-3 RT for any indication. There is no Notice of Compliance and no DIN, so it cannot be sold as a medicine in Canada and is not stocked by Canadian pharmacies.

When will GLP-3 RT be available in Canada?

No date can be given. GLP-3 RT is investigational, Health Canada has published no review timeline for it, and any Canadian authorisation would follow Health Canada's own separate review.

Can you buy GLP-3 RT in Canada in 2026?

Not as a medicine. No authorized GLP-3 RT product exists in Canada, so there is nothing a pharmacy can dispense and no prescription that can be written for it. What is sold online is research material rather than an approved drug, and is supplied for in-vitro laboratory use only.

Does GLP-3 RT have a Health Canada DIN?

No. A DIN is issued only after Health Canada authorizes a product for sale. GLP-3 RT is investigational, so no DIN exists and any product presented as carrying one is misrepresented.

Compound research hub

GLP-3 RT: Research, Handling and Batch Documentation

GLP-3 RT (LY3437943) is an investigational acylated peptide and a triple agonist at the GLP-1, GIP and glucagon receptors, approved by no regulator.

Part of Volta's peptides.

Identity and specification

Form: Lyophilized powder
Appearance: White lyophilised powder
Other known names: LY3437943
Compound class: GLP-1, GIP and glucagon receptor triple agonist
CAS number: 2381089-83-2
Molecular formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular weight: 4,731.4 g/mol
PubChem SID: 474492335
Production: Synthetic, by solid-phase peptide synthesis
Solubility: Soluble in sterile water
Shelf life: 24 months from date of manufacture

Vial sizes available

Every size of GLP-3 RT Volta lists, in stock or not. Each is a separate catalogue page with its own batch number and specification table.

GLP-3 RT 10mg 10mgBatch #: VPRT10100
In stock
GLP-3 RT 20mg 20mgBatch #: VPRT20100
In stock
GLP-3 RT 30mg 30mgBatch #: VPRT30100
Restocking
GLP-3 RT 5mg 5mgBatch #: VPRT5100
Restocking

Purity and batch documentation

Volta's release specification is >99% (HPLC). That is a threshold we set. >99% is the specification every batch is released to. The figure on a certificate is what a laboratory measured for one lot.

SideChain Analytics reported 99.7% by HPLC-MS/MS on September 16, 2026, lot VPRT20100.
Covers the 20mg vial. Results relate to the sample as received and are not a measurement of the other fills.
Read the certificate Verify on lab's website (Verify on SideChain Analytics's website, opens in a new tab)

the complete batch history dataset how each batch is tested laboratories that test peptides independently

Research on GLP-3 RT

Comparisons

Handling and stability

Laboratory guides

storage and stability in solution

Regulatory context

GLP-3 RT in Canada

GLP-3 RT is not authorized for sale in Canada. It is an investigational compound, and no approved GLP-3 RT product exists at any Canadian pharmacy or clinic.

Health Canada has issued no Notice of Compliance and no Drug Identification Number (DIN) for GLP-3 RT. A drug with no DIN cannot lawfully be sold as a medicine in Canada.
Health Canada has published no review timeline for GLP-3 RT, so no Canadian availability date can be stated.
Material supplied for in-vitro laboratory research is not the clinical trial formulation, is not a medicine, is not dispensed against a prescription, and is not authorised for human use.

Is GLP-3 RT approved in Canada?: No. Health Canada has not authorized GLP-3 RT for any indication. There is no Notice of Compliance and no DIN, so it cannot be sold as a medicine in Canada and is not stocked by Canadian pharmacies.
When will GLP-3 RT be available in Canada?: No date can be given. GLP-3 RT is investigational, Health Canada has published no review timeline for it, and any Canadian authorisation would follow Health Canada's own separate review.
Can you buy GLP-3 RT in Canada in 2026?: Not as a medicine. No authorized GLP-3 RT product exists in Canada, so there is nothing a pharmacy can dispense and no prescription that can be written for it. What is sold online is research material rather than an approved drug, and is supplied for in-vitro laboratory use only.
Does GLP-3 RT have a Health Canada DIN?: No. A DIN is issued only after Health Canada authorizes a product for sale. GLP-3 RT is investigational, so no DIN exists and any product presented as carrying one is misrepresented.

Regulatory position verified 2026-09-28. Positions change; this page states the date it was last checked rather than implying it is current.

More peptides

GLP-3 RT sits in Volta's peptides group, alongside the other compounds of the same composition. The whole range is on the full research catalogue, and the library of comparisons and guides is under peptide research.